Cover Image

DNA mismatch repair deficient (dMMR) endometrial cancer

Saved in:

Bibliographic Details
Main Authors:	Chia-Hao Liu (Author), Szu-Ting Yang (Author), Peng-Hui Wang (Author)
Format:	Book
Published:	Elsevier, 2022-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Activity of pembrolizumab and lenvatinib in mismatch repair deficient (dMMR) endometrial cancer patients who have failed pembrolizumab monotherapy: A case series
by: Peter G. Rose, et al.
Published: (2023)

An unusual case of microsatellite instability-high/deficient mismatch repair (MSI-H/dMMR) diffuse large B-cell lymphoma revealed by targeted gene sequencing
by: Bogyeong Han, et al.
Published: (2022)

Molecular Profiling of H-MSI/dMMR/for Endometrial Cancer Patients: "New Challenges in Diagnostic Routine Practice"
by: Riccardo Adorisio, et al.
Published: (2024)

Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment for mismatch-repair-deficient (dMMR) or microsatellite-instability-high (MSI-H) advanced or metastatic colorectal cancer from the perspective of the Chinese health-care system
by: Chen Zhu, et al.
Published: (2023)

Assessment of Immune Status in Patients with Mismatch Repair Deficiency Endometrial Cancer
by: Ma J, et al.
Published: (2024)

Clinicopathologic significance of DNA mismatch repair protein status in endometrial cancer
by: Ju-Hyun Kim, et al.
Published: (2022)

Mismatch repair deficiency in bilateral breast cancer
by: Milena Massumi Kozonoe, et al.
Published: (2024)

Immunohistochemistry Staining for the Mismatch Repair Proteins in Endometrial Cancer Patients
by: Pimpitcha Puangsricharoen, et al.
Published: (2020)

Mismatch repair deficiency and clinicopathological characteristics in endometrial carcinoma: a systematic review and meta-analysis
by: Alaa Salah Jumaah, et al.
Published: (2021)

Low frequency of mismatch repair deficiency in gallbladder cancer
by: Benjamin Goeppert, et al.
Published: (2019)

Clinicopathologic significance of mismatch repair protein expression in endometrioid endometrial cancer
by: Mi-Kyung Kim, et al.
Published: (2023)

Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation
by: Aoife J McCarthy, et al.
Published: (2019)

Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer that are non-microsatellite instability high (non-MSI-high) or mismatch repair proficient (pMMR) in the United States
by: Sneha S. Kelkar, et al.
Published: (2022)

Digging into phenotype change in mismatch repair deficient endometrial carcinoma and treatment with immune checkpoint inhibition, a case report
by: Macarena Rey-Cárdenas, et al.
Published: (2023)

Sentinel-lymph-node mapping in endometrial cancer: Tumor location matters?
by: Chia-Hao Liu, et al.
Published: (2024)

Screening of Lynch syndrome in endometrial cancer in Iranian population with mismatch repair protein by immunohistochemistry
by: Somayyeh Noei Teymoordash, et al.
Published: (2022)

Precision unleashed: tackling DNA mismatch repair for enhanced prime editing
by: Rohin Ramchandani, et al.
Published: (2023)

Primary fallopian tube cancer mimics endometrial cancer: A diagnostic challenge
by: Yu-Chia Hu, et al.
Published: (2023)

Homozygous germ-line mutation of the PMS2 mismatch repair gene: a unique case report of constitutional mismatch repair deficiency (CMMRD)
by: N. C. Ramchander, et al.
Published: (2017)

Microsatellite instability and mismatch repair protein deficiency: equal predictive markers?
by: Maja L. Nádorvári, et al.
Published: (2024)

Potential predictors for CDX2 expression loss and mismatch repair deficiency in colorectal cancer
by: Ivan Vlahović, et al.
Published: (2023)

Expression of programmed cell death ligand-1 and mismatch repair status in endometrial carcinomas
by: Madhubala Rajendran, et al.
Published: (2023)

DEEP MULTI-INSTANCE LEARNING FOR PREDICTING MISMATCH REPAIR DEFICIENCY IN COLON BIOPSIES
by: Sasa Andjelkovic, et al.
Published: (2022)

miR-1290 Is a Biomarker in DNA-Mismatch-Repair-Deficient Colon Cancer and Promotes Resistance to 5-Fluorouracil by Directly Targeting hMSH2
by: Ling Ye, et al.
Published: (2017)

Mismatch repair protein deficiency in endometriosis: Precursor of endometriosis-associated ovarian cancer in women with lynch syndrome
by: Munekage Yamaguchi, et al.
Published: (2023)

miR675 Accelerates Malignant Transformation of Mesenchymal Stem Cells by Blocking DNA Mismatch Repair
by: Yanan Lu, et al.
Published: (2019)

Cost-effectiveness analysis of lenvatinib plus pembrolizumab compared with chemotherapy for patients with previously treated mismatch repair proficient advanced endometrial cancer in China
by: Zhiwei Zheng, et al.
Published: (2022)

PMS2 gene mutation results in DNA mismatch repair system failure in a case of adult granulosa cell tumor
by: Wen-Chung Wang, et al.
Published: (2017)

DNA recombinase Rad51 is regulated with UVinduced DNA damage and the DNA mismatch repair inhibitor CdCl2 in HC11 cells
by: Hyeong-Ju You, et al.
Published: (2021)

Endometrial cancer: Part I. Basic concept
by: Peng-Hui Wang, et al.
Published: (2022)

A novel somatic mutation in POLE exonuclease domain associated with ultra-mutational signature and MMR deficiency in endometrial cancer: a case report
by: Jiantao Cui, et al.
Published: (2023)

Sebaceous "adenoma" of an arm recurring as a carcinoma: The value of DNA mismatch repair gene expression immunohistochemistry
by: Ryan C. Saal, BS, et al.
Published: (2022)

Oncological characteristics, treatments and prognostic outcomes in MMR-deficient colorectal cancer
by: Wen-Xuan Fan, et al.
Published: (2024)

Sporadic colorectal polyps and mismatch repair proteins
by: Mahsa Molaei, et al.
Published: (2011)

Molecular pathology and prognosis of endometrial cancer
by: Yiu-Tai Li, et al.
Published: (2022)

Resistance to immune checkpoint inhibitors in colorectal cancer with deficient mismatch repair/microsatellite instability: misdiagnosis, pseudoprogression and/or tumor heterogeneity?
by: Nicola Normanno, et al.
Published: (2024)

Cost-Effectiveness of First-Line Versus Second-Line Pembrolizumab or Chemotherapy in Patients With Microsatellite-Instability-High/Mismatch Repair-Deficient Advanced Colorectal Cancer
by: Tan Chongqing, et al.
Published: (2021)

Cylindromatosis (CYLD) expression and prognosis of endometrial cancer
by: Yiu-Tai Li, et al.
Published: (2022)

Minimally invasive surgery for endometrial cancer: The better choice?
by: Yiu-Tai Li, et al.
Published: (2024)

DNA Mismatch Repair Proteins and BRAF V600E Detection by Immunohistochemistry in Colorectal Cancer Demonstrates Concordance with Next Generation Sequencing
by: Joel Yambert, et al.
Published: (2022)